Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17044868rdf:typepubmed:Citationlld:pubmed
pubmed-article:17044868lifeskim:mentionsumls-concept:C0021027lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C1421563lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C1415497lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C0086222lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:17044868lifeskim:mentionsumls-concept:C1705733lld:lifeskim
pubmed-article:17044868pubmed:issuePt 6lld:pubmed
pubmed-article:17044868pubmed:dateCreated2006-10-18lld:pubmed
pubmed-article:17044868pubmed:abstractTextThe human HS1,2 enhancer of the immunoglobulin (Ig) heavy chain 3' enhancer complex plays a central role in the regulation of Ig maturation and production. Four common alleles HS1,2-A*1, *2, *3, *4 are directly implicated with the transcription level and at least one of them, HS1, 2-A*2, seems to be related to immune disorders, such as coeliac disease, herpetiform dermatitis and Berger syndrome. Given their clinical significance it is of interest to know the distribution of HS1,2-A variants in populations from different continents, as well as to determine whether the polymorphism is associated to specific evolutionary factors. In this paper we report the distribution of the HS1,2-A polymorphism in 1098 individuals from various African, Asian and European populations. HS1,2-A*3 and HS1,2-A*4 alleles are at their highest frequencies among Africans, and HS1,2-A*2 is significantly lower in Africans in comparison with both Europeans and, to a lesser extent, Asians. Analysis of molecular variance of the allele frequencies indicates that the HS1,2-A polymorphism can be considered as a reliable anthropogenetic marker.lld:pubmed
pubmed-article:17044868pubmed:languageenglld:pubmed
pubmed-article:17044868pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17044868pubmed:citationSubsetIMlld:pubmed
pubmed-article:17044868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17044868pubmed:statusMEDLINElld:pubmed
pubmed-article:17044868pubmed:monthNovlld:pubmed
pubmed-article:17044868pubmed:issn0003-4800lld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:FrezzaDDlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:CrawfordMMlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:BiondiGGlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:ModianoDDlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:RickardsOOlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:Martínez-Laba...lld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:FrancavillaRRlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:SimporéJJlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:KilicS SSSlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:ZhelezovaGGlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:GiambraVVlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:GiufréMMlld:pubmed
pubmed-article:17044868pubmed:authorpubmed-author:GisladottirB...lld:pubmed
pubmed-article:17044868pubmed:issnTypePrintlld:pubmed
pubmed-article:17044868pubmed:volume70lld:pubmed
pubmed-article:17044868pubmed:ownerNLMlld:pubmed
pubmed-article:17044868pubmed:authorsCompleteYlld:pubmed
pubmed-article:17044868pubmed:pagination946-50lld:pubmed
pubmed-article:17044868pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:meshHeadingpubmed-meshheading:17044868...lld:pubmed
pubmed-article:17044868pubmed:year2006lld:pubmed
pubmed-article:17044868pubmed:articleTitleImmunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker.lld:pubmed
pubmed-article:17044868pubmed:affiliationDipartamento Biologia E. Calef, Università di Roma Tor Vergata, Viale della ricerca scientifica, 00133 Rome, Italy.lld:pubmed
pubmed-article:17044868pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17044868pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3500entrezgene:pubmedpubmed-article:17044868lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17044868lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17044868lld:pubmed